Cargando…
Dysregulated immunity in PID patients with low GARP expression on Tregs due to mutations in LRRC32
Immune dysregulation diseases are characterized by heterogeneous clinical manifestations and may have severe disease courses. The identification of the genetic causes of these diseases therefore has critical clinical implications. We performed whole-exome sequencing of patients with immune dysregula...
Autores principales: | Lehmkuhl, Peter, Gentz, Magdalena, Garcia de Otezya, Andres Caballero, Grimbacher, Bodo, Schulze-Koops, Hendrik, Skapenko, Alla |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8245512/ https://www.ncbi.nlm.nih.gov/pubmed/34059789 http://dx.doi.org/10.1038/s41423-021-00701-z |
Ejemplares similares
-
FOXP3 and GARP (LRRC32): the master and its minion
por: Probst-Kepper, Michael, et al.
Publicado: (2010) -
Mesenchymal Stromal Cells Express GARP/LRRC32 on Their Surface: Effects on Their Biology and Immunomodulatory Capacity
por: Carrillo-Galvez, Ana Belén, et al.
Publicado: (2015) -
Biosimilars in rheumatology: A review of the evidence and their place in the treatment algorithm
por: Schulze-Koops, Hendrik, et al.
Publicado: (2017) -
COVID-19 vaccination in individuals with inflammatory rheumatic diseases
por: Skapenko, Alla, et al.
Publicado: (2022) -
Vaccination of patients with inflammatory rheumatic diseases against SARS-CoV-2: considerations before widespread availability of the vaccines
por: Schulze-Koops, Hendrik, et al.
Publicado: (2021)